Get started
Author

Nehal Gupta

Observed name: Gupta, Nehal
ORCID: 0000-0002-8931-5759
Observed ORCID: 0000-0002-8931-5759
OpenAlex ID: A5031458800
Role of Phytochemicals in Cancer Prevention
2019 · Alok Ranjan, Sharavan Ramachandran, et al. · International Journal of Molecular Sciences · 369
PDF
Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin
2020 · Nehal Gupta, Kshitij Verma, et al. · Molecules · 161
PDF
Cancer cells stemness: A doorstep to targeted therapy
2019 · Sahdeo Prasad, Sharavan Ramachandran, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 157
Role of Forkhead Box Class O proteins in cancer progression and metastasis
2017 · Chang Geun Kim, Hyemin Lee, et al. · Seminars in Cancer Biology · 103
Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
2019 · Nehal Gupta, Parul Gupta, et al. · Scientific Reports · 63
PDF
AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
2018 · Kshitij Verma, Nehal Gupta, et al. · Molecular Cancer Therapeutics · 54
Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines
2016 · Kshitij Verma, Tianzhu Zang, et al. · ACS Medicinal Chemistry Letters · 46
HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells
2018 · Parul Gupta, Nehal Gupta, et al. · Cancer Letters · 43
Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling
2019 · Nehal Gupta, Sanjay K. Srivastava · Molecular Cancer Therapeutics · 42
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
2021 · Nehal Gupta, Shreyas Gaikwad, et al. · International Journal of Molecular Sciences · 35
PDF
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
2020 · Suyash Srivastava, Fatema Tuz Zahra, et al. · International Journal of Molecular Sciences · 18
PDF
Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer
2022 · Ji Won Kim, Cuyler Luck, et al. · Cell Reports · 15
Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
2021 · Nehal Gupta, Sanjay K. Srivastava · Pharmaceuticals · 14
PDF
The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression
2022 · Nehal Gupta, Hanbing Song, et al. · eLife · 10
Proguanil Suppresses Breast Tumor Growth In Vitro and In Vivo by Inducing Apoptosis via Mitochondrial Dysfunction
2024 · Nehal Gupta, Marina Curcic, et al. · Cancers · 7
Abstract 3176: Inhibition of HER2/β-catenin signaling by penfluridol overcomes resistance to paclitaxel in breast cancer
2017 · Nehal Gupta, Parul Gupta, et al. · Cancer Research · 1
Abstract 1378: Proguanil inhibits breast cancer in vitro and in vivo through mitochondrial dysfunction
2023 · Marina Curcic, Nehal Gupta, et al. · Cancer Research
Data from AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
2023 · Kshitij Verma, Nehal Gupta, et al.
Supplementary Fig 3 from Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling
2023 · Nehal Gupta, Sanjay K. Srivastava
Supplementary Fig 1 from Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling
2023 · Nehal Gupta, Sanjay K. Srivastava
Supplementary Fig 4 from Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling
2023 · Nehal Gupta, Sanjay K. Srivastava
Supplementary Fig 2 from Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling
2023 · Nehal Gupta, Sanjay K. Srivastava
Figure S4 & S5 from AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
2023 · Kshitij Verma, Nehal Gupta, et al.
Figure S9 from AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
2023 · Kshitij Verma, Nehal Gupta, et al.
Figure S3 from AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
2023 · Kshitij Verma, Nehal Gupta, et al.
Works count: 58
Citation count: 1,138
H-index: 13
I10-index: 14
Year
Topic
Type